Homozygous Familial Hypercholesterolemia (HoFH) Latest Advances

Find the Latest Research About Homozygous Familial Hypercholesterolemia (HoFH)

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1941 publications

Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia: A Nonrandomized Clinical Trial.

Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia: A Nonrandomized Clinical Trial.

Journal: JAMA cardiology
Published: January 07, 2026

Genetic Testing for Children with Familial Hypercholesterolemia.

Genetic Testing for Children with Familial Hypercholesterolemia.

Journal: Journal of atherosclerosis and thrombosis
Published: December 17, 2025

The Genetic Landscape of Familial Hypercholesterolemia in Telangana, Southern India: Novel Mutations and Clinical Implications.

The Genetic Landscape of Familial Hypercholesterolemia in Telangana, Southern India: Novel Mutations and Clinical Implications.

Journal: Cureus
Published: December 12, 2025

Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent.

Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent.

Journal: Current opinion in lipidology
Published: November 05, 2025

Genotype and phenotype of familial hypercholesterolemia in Egyptian children: a single-center study.

Genotype and phenotype of familial hypercholesterolemia in Egyptian children: a single-center study.

Journal: Journal of tropical pediatrics
Published: October 29, 2025

Clinical and Subclinical Atherosclerotic Disease in Adolescents With Familial Hypercholesterolemia.

Clinical and Subclinical Atherosclerotic Disease in Adolescents With Familial Hypercholesterolemia.

Journal: JACC. Case reports
Published: October 27, 2025

Evinacumab in patients aged 5-17 years with homozygous familial hypercholesterolemia.

Evinacumab in patients aged 5-17 years with homozygous familial hypercholesterolemia.

Journal: Atherosclerosis
Published: October 16, 2025

Diagnostic and Therapeutic Challenges of Homozygous and Severe Heterozygous Familial Hypercholesterolemia from Clinical Aspect-A Single-Center Study.

Diagnostic and Therapeutic Challenges of Homozygous and Severe Heterozygous Familial Hypercholesterolemia from Clinical Aspect-A Single-Center Study.

Journal: Journal of clinical medicine
Published: October 12, 2025

Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia.

Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia.

Journal: JACC. Case reports
Published: October 10, 2025

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

Journal: Journal of atherosclerosis and thrombosis
Published: October 08, 2025

Long-Standing Bilateral Adult-Onset Orbital Xanthogranuloma With Unique Histologic Findings Uncovering the Diagnosis of Sitosterolemia.

Long-Standing Bilateral Adult-Onset Orbital Xanthogranuloma With Unique Histologic Findings Uncovering the Diagnosis of Sitosterolemia.

Journal: The American Journal of dermatopathology
Published: October 01, 2025

Clinical features of familial hypercholesterolemia in children

Clinical features of familial hypercholesterolemia in children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: September 17, 2025
Showing 1-12 of 1,941

Last Updated: 02/24/2026